Much Ado About Something:
RSV & the Older Adult
Epidemiology & Burden of Disease
This CME-certified Tweetorial aims to close knowledge gaps and improve awareness of the significant morbidity and mortality caused by Respiratory Syncytial Virus (RSV) infection, especially in older adults. This activity will address RSV prevalence, sheds light on the burden of RSV, risk factors for complications and severe disease in adults, the impact of COVID-19 on RSV, seasonality, and hospitalization data.
Tweetorial #1
This activity is jointly provided by Global Education Group and Bonum CE.
Supported by educational grant from Janssen Therapeutics, Inc., division of Janssen Products, LP.
Diagnosis
This CME-certified Tweetorial activity focuses on the symptom profile of Respiratory Syncytial Virus (RSV), symptom overlap with other respiratory tract infections, methods for detecting and confirming an RSV diagnosis; specifically reviewing available tests including specificity and sensitivity data.
Tweetorial #2
Epidemiology, Burden of Disease, and Diagnosis of RSV
This hour-long webinar will increase clinician knowledge about RSV including discussing epidemiology and burden of disease, review characteristics that put patients at higher risk of moderate to severe RSV, and improve clinician understanding of diagnostic testing.
Broadcast #1
RSV Vaccines: Protein Subunits
This Twitter-based, CME-certified Tweetorial activity will focus on Respiratory Syncytial Virus (RSV) mitigation strategies and delve into the pros and cons of vaccine candidates, specifically the development of protein subunits vaccines for older adults.
Tweetorial #3
RSV Vaccines: Adenovirus Type 26 Viral Vectors
This Twitter-based, CME-certified Tweetorial activity will focus on Respiratory Syncytial (RSV) Adenovirus Type 26 Viral Vectors vaccine candidates, how they work, their effectiveness, and safety information.
Tweetorial #4